Logo image of TVTX

TRAVERE THERAPEUTICS INC (TVTX) Stock Analyst Ratings

NASDAQ:TVTX - Nasdaq - US89422G1076 - Common Stock - Currency: USD

21.1  +0.97 (+4.82%)

After market: 21.26 +0.16 (+0.76%)

Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to TVTX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 28.15. This target is 33.42% above the current price.
TVTX was analyzed by 21 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about TVTX.
In the previous month the buy percentage consensus was at a similar level.
TVTX was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
TVTX Historical Analyst RatingsTVTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -97 -88 -79 -70 -61 -52 -43 -34 -25 -16 -7 5 10 15 20

Price Target & Forecast

Price Low Median Mean High 21.1018.1825.5028.1544.10 - -13.84% 20.85% 33.42% 109.00%
TVTX Current Analyst RatingTVTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8
Up and Down Grades
Date Firm Action Rating
2025-01-15 HC Wainwright & Co. Maintains Buy -> Buy
2024-11-14 Piper Sandler Maintains Neutral -> Neutral
2024-11-01 ScotiaBank Maintains Sector Outperform -> Sector Outperform
2024-11-01 Barclays Maintains Overweight -> Overweight
2024-10-21 Wells Fargo Upgrade Equal-Weight -> Overweight
2024-10-16 ScotiaBank Initiate Sector Outperform
2024-10-11 Leerink Partners Maintains Outperform -> Outperform
2024-10-09 Guggenheim Maintains Buy -> Buy
2024-10-09 Wedbush Maintains Outperform -> Outperform
2024-10-09 B of A Securities Maintains Buy -> Buy
2024-10-08 Leerink Partners Reiterate Outperform -> Outperform
2024-10-01 Barclays Maintains Overweight -> Overweight
2024-09-30 Canaccord Genuity Maintains Buy -> Buy
2024-09-27 Guggenheim Maintains Buy -> Buy
2024-09-27 B of A Securities Maintains Buy -> Buy
2024-09-27 Citigroup Maintains Buy -> Buy
2024-09-27 HC Wainwright & Co. Maintains Buy -> Buy
2024-09-13 JP Morgan Maintains Overweight -> Overweight
2024-09-10 Canaccord Genuity Maintains Buy -> Buy
2024-09-09 Guggenheim Upgrade Neutral -> Buy
2024-09-06 B of A Securities Maintains Buy -> Buy
2024-09-06 Citigroup Maintains Buy -> Buy
2024-09-06 HC Wainwright & Co. Maintains Buy -> Buy
2024-08-13 JP Morgan Maintains Overweight -> Overweight
2024-08-05 HC Wainwright & Co. Maintains Buy -> Buy
2024-08-02 Barclays Maintains Overweight -> Overweight
2024-08-02 Wedbush Maintains Outperform -> Outperform
2024-08-02 Piper Sandler Maintains Neutral -> Neutral
2024-05-07 Canaccord Genuity Maintains Buy -> Buy
2024-05-07 HC Wainwright & Co. Reiterate Buy -> Buy